BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 36376561)

  • 1. Beyond PI3Ks: targeting phosphoinositide kinases in disease.
    Burke JE; Triscott J; Emerling BM; Hammond GRV
    Nat Rev Drug Discov; 2023 May; 22(5):357-386. PubMed ID: 36376561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugging the Phosphoinositide 3-Kinase (PI3K) and Phosphatidylinositol 4-Kinase (PI4K) Family of Enzymes for Treatment of Cancer, Immune Disorders, and Viral/Parasitic Infections.
    McPhail JA; Burke JE
    Adv Exp Med Biol; 2020; 1274():203-222. PubMed ID: 32894512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Basis for Regulation of Phosphoinositide Kinases and Their Involvement in Human Disease.
    Burke JE
    Mol Cell; 2018 Sep; 71(5):653-673. PubMed ID: 30193094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergy in activating class I PI3Ks.
    Burke JE; Williams RL
    Trends Biochem Sci; 2015 Feb; 40(2):88-100. PubMed ID: 25573003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Overview of Class II Phosphoinositide 3-Kinases.
    Heng EYZ; Maffucci T
    Curr Top Microbiol Immunol; 2022; 436():51-68. PubMed ID: 36243839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lipid products of phosphoinositide 3-kinase isoforms in cancer and thrombosis.
    Anquetil T; Payrastre B; Gratacap MP; Viaud J
    Cancer Metastasis Rev; 2018 Sep; 37(2-3):477-489. PubMed ID: 29868934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphoinositide 3-Kinases as Potential Targets for Thrombosis Prevention.
    Setiabakti NM; Larsson P; Hamilton JR
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases.
    Dornan GL; Burke JE
    Front Immunol; 2018; 9():575. PubMed ID: 29616047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PI4KA and PIKfyve: Essential phosphoinositide signaling enzymes involved in myriad human diseases.
    Barlow-Busch I; Shaw AL; Burke JE
    Curr Opin Cell Biol; 2023 Aug; 83():102207. PubMed ID: 37453227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective phosphoinositide metabolism in autism.
    Gross C
    J Neurosci Res; 2017 May; 95(5):1161-1173. PubMed ID: 27376697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring Activity of Phosphoinositide Lipid Kinases Using a Bioluminescent ADP-Detecting Assay.
    Tai AW; Vidugiriene J
    Methods Mol Biol; 2016; 1360():75-85. PubMed ID: 26501903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for activation and inhibition of class I phosphoinositide 3-kinases.
    Vadas O; Burke JE; Zhang X; Berndt A; Williams RL
    Sci Signal; 2011 Oct; 4(195):re2. PubMed ID: 22009150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphoinositide 3-kinase assay in breast cancer cell extracts.
    Bilancio A; Migliaccio A
    Methods Mol Biol; 2014; 1204():145-53. PubMed ID: 25182768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanism of activation of class IA phosphoinositide 3-kinases (PI3Ks) by membrane-localized HRas.
    Siempelkamp BD; Rathinaswamy MK; Jenkins ML; Burke JE
    J Biol Chem; 2017 Jul; 292(29):12256-12266. PubMed ID: 28515318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Present and future of PI3K pathway inhibition in cancer: perspectives and limitations.
    Ciraolo E; Morello F; Hirsch E
    Curr Med Chem; 2011; 18(18):2674-85. PubMed ID: 21649577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods to measure the enzymatic activity of PI3Ks.
    Ciraolo E; Gulluni F; Hirsch E
    Methods Enzymol; 2014; 543():115-40. PubMed ID: 24924130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide analysis of the phosphoinositide kinome from two ciliates reveals novel evolutionary links for phosphoinositide kinases in eukaryotic cells.
    Leondaritis G; Siokos J; Skaripa I; Galanopoulou D
    PLoS One; 2013; 8(11):e78848. PubMed ID: 24244373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammalian phosphoinositide kinases and phosphatases.
    Sasaki T; Takasuga S; Sasaki J; Kofuji S; Eguchi S; Yamazaki M; Suzuki A
    Prog Lipid Res; 2009 Nov; 48(6):307-43. PubMed ID: 19580826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemical biology of phosphoinositide 3-kinases.
    Wymann MP; Schultz C
    Chembiochem; 2012 Sep; 13(14):2022-35. PubMed ID: 22965647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoinositide kinases.
    Fruman DA; Meyers RE; Cantley LC
    Annu Rev Biochem; 1998; 67():481-507. PubMed ID: 9759495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.